---
title: "TransMedics Group, Inc. Stock 12‑Month Price Target Cut to $97.6, Implies 21% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294940425.md"
description: "TransMedics Group, Inc.'s 12-month average price target was lowered from $106 to $102.5 by 10 analysts, with individual forecasts ranging from $65 to $125. Based on the August 4 closing price, this implies approximately 27% potential upside. The consensus rating remains 'Buy' across the 12 covering analysts, comprising 8 Buys and 4 Holds."
datetime: "2026-08-05T09:20:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294940425.md)
  - [en](https://longbridge.com/en/news/294940425.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294940425.md)
generator: "portal-rs"
---

# TransMedics Group, Inc. Stock 12‑Month Price Target Cut to $97.6, Implies 21% Upside

-   According to estimates from 10 analysts, TransMedics Group, Inc. stock's average price target has fallen from $106 to $102.5, with forecasts ranging from $65 to $125 per share
-   Based on the Aug. 4 closing price, the updated target implies approximately 27% potential upside
-   Consensus rating remains at “Buy” across 12 covering analysts, with 8 Buys, 4 Holds and 0 Sells

Explore more price target data and ratings for TransMedics Group, Inc. on the , and track all previous and future analyst recommendations for TransMedics Group, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TMDX.US](https://longbridge.com/en/quote/TMDX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Is TransMedics Group (TMDX) Fairly Valued As Revenue Grew And 2026 Guidance Was Raised?](https://longbridge.com/en/news/296030563.md)
- [Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?](https://longbridge.com/en/news/296066899.md)
- [07:45 ETRosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX](https://longbridge.com/en/news/296613617.md)
- [TransMedics Targets $2B Opportunity With Kidney Push, European Expansion](https://longbridge.com/en/news/296178365.md)
- [TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX](https://longbridge.com/en/news/296122272.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**